Helsinki, Finland

Reijo Bäckström


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Reijo Bäckström: Innovator in Pharmaceutical Solutions

Introduction

Reijo Bäckström is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solutions for treating congestive heart failure. With a total of 4 patents to his name, Bäckström's work has had a meaningful impact on medical treatments.

Latest Patents

Among his latest patents is the invention of pharmaceutical solutions of levosimendan. These solutions are designed for pharmaceutical use, specifically for intravenous administration. The enhanced stability of these solutions makes them particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is recognized for its effectiveness in treating congestive heart failure. Another notable patent involves pyridazinyl phenyl hydrazones, which are also useful against congestive heart failure.

Career Highlights

Reijo Bäckström is associated with Orion Corporation, a leading company in the pharmaceutical industry. His work at Orion has allowed him to focus on innovative solutions that address critical health issues. His contributions have been instrumental in advancing treatment options for patients suffering from heart conditions.

Collaborations

Bäckström has collaborated with several professionals in his field, including Kari Lönnberg and Aino K Pippuri. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Reijo Bäckström's work exemplifies the importance of innovation in the pharmaceutical industry. His patents and contributions continue to pave the way for advancements in the treatment of congestive heart failure.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…